Left Menu
Development News Edition

WRAPUP 5-AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same next week

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial as early as next week, the companies said on Friday. AstraZeneca's U.S. trial was paused on Sept.

Reuters | Washington DC | Updated: 24-10-2020 02:45 IST | Created: 24-10-2020 02:15 IST
WRAPUP 5-AstraZeneca resumes U.S. COVID-19 vaccine trial and J&J prepares to do same next week
Representative image Image Credit: ANI

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial as early as next week, the companies said on Friday.

AstraZeneca's U.S. trial was paused on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial. J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating. J&J said on Friday that the safety panel, called a Data and Safety Monitoring Board, has recommended that the drugmaker resume trial recruitment after finding no evidence that the vaccine caused the volunteer to fall ill.

J&J expects to resume its trial on Monday or Tuesday of next week and remains on track to produce data from the trial on the vaccines' effectiveness by the end of 2020 or early 2021, J&J's chief scientific officer Paul Stoffels said. J&J is also in discussions with other regulators to resume a trial outside of the United States as well, the company said.

So far, the medical board has not identified a clear cause for the patients' illness. AstraZeneca trials in the United Kingdom, Brazil and South Africa resumed last month even as the U.S. Food and Drug Administration continued its investigation into the case.

Reuters earlier this week reported that the FDA had completed its review and that the AstraZeneca U.S. trial was set to resume as early as this week, citing four sources familiar with the situation. AstraZeneca's vaccine is being developed along with researchers at Oxford University.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

COVID-19 recovery, focus of UN General Assembly special session

Today marks an overdue and much needed moment of reckoning. None of us could have imagined, this time last year, what was to come, said Assembly President Volkan Bozkir, speaking at the opening of the two-day gathering. We are working for...

New Africa alliance aims to tackle deadly COVID ‘infodemic’

The Africa Infodemic Response Alliance AIRA, brings together 13 international and regional organizations, together with fact-checking groups which have expertise in data and behavioural science, epidemiology, research, digital health and ...

Aid coming to north Ethiopia, refugees recount war suffering

A senior European Union official said on Thursday December 3 that providing swift humanitarian relief in Ethiopia was challenging because aid workers still did not have unimpeded access.Humanitarian groups are therefore unable to assess th...

Indian government to meet protesting farmers again on Saturday as talks continue

The fourth round of talks between the Indian government and 40 farmers unions over divisive farm laws failed to make headway on Thursday December 3 but a cabinet minister said they would continue discussions on Saturday December 5.In Indias...

Give Feedback